[{"Assets_0_Q1_USD":250055000.0,"CommonStockDividendsPerShareDeclared_1_Q1_USD":0.2,"EarningsPerShareBasic_1_Q1_USD":0.15,"EarningsPerShareDiluted_1_Q1_USD":0.15,"NetIncomeLoss_1_Q1_USD":6279000.0,"StockholdersEquity_0_Q1_USD":165732000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":42535000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":42159000.0,"Ticker":"VIVO","CIK":"794172","name":"MERIDIAN BIOSCIENCE INC","OfficialName":"Meridian Bioscience Inc. Common Stock","form":"10-Q","period":"20161231","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1192599275.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20170209"}]